Smith, Moore & Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-7,826
| Closed | -$426K | – | 388 |
|
2022
Q2 | $426K | Sell |
7,826
-640
| -8% | -$34.8K | 0.07% | 241 |
|
2022
Q1 | $461K | Sell |
8,466
-384
| -4% | -$20.9K | 0.06% | 255 |
|
2021
Q4 | $488K | Buy |
8,850
+432
| +5% | +$23.8K | 0.07% | 242 |
|
2021
Q3 | $402K | Sell |
8,418
-32
| -0.4% | -$1.53K | 0.06% | 261 |
|
2021
Q2 | $421K | Buy |
8,450
+1,104
| +15% | +$55K | 0.06% | 257 |
|
2021
Q1 | $328K | Buy |
7,346
+22
| +0.3% | +$982 | 0.05% | 279 |
|
2020
Q4 | $337K | Sell |
7,324
-1,986
| -21% | -$91.4K | 0.06% | 251 |
|
2020
Q3 | $438K | Buy |
9,310
+1,616
| +21% | +$76K | 0.09% | 211 |
|
2020
Q2 | $392K | Sell |
7,694
-891
| -10% | -$45.4K | 0.09% | 209 |
|
2020
Q1 | $407K | Buy |
8,585
+2,468
| +40% | +$117K | 0.11% | 172 |
|
2019
Q4 | $359K | Sell |
6,117
-2,020
| -25% | -$119K | 0.07% | 229 |
|
2019
Q3 | $434K | Sell |
8,137
-978
| -11% | -$52.2K | 0.1% | 199 |
|
2019
Q2 | $456K | Buy |
9,115
+4
| +0% | +$200 | 0.1% | 194 |
|
2019
Q1 | $476K | Buy |
9,111
+1,076
| +13% | +$56.2K | 0.11% | 178 |
|
2018
Q4 | $384K | Sell |
8,035
-2,054
| -20% | -$98.2K | 0.1% | 196 |
|
2018
Q3 | $507K | Buy |
10,089
+247
| +3% | +$12.4K | 0.12% | 166 |
|
2018
Q2 | $496K | Buy |
9,842
+1,765
| +22% | +$88.9K | 0.12% | 156 |
|
2018
Q1 | $394K | Sell |
8,077
-1,881
| -19% | -$91.8K | 0.11% | 188 |
|
2017
Q4 | $442K | Buy |
9,958
+372
| +4% | +$16.5K | 0.12% | 173 |
|
2017
Q3 | $486K | Buy |
9,586
+2,065
| +27% | +$105K | 0.14% | 143 |
|
2017
Q2 | $405K | Buy |
7,521
+164
| +2% | +$8.83K | 0.14% | 144 |
|
2017
Q1 | $388K | Buy |
7,357
+213
| +3% | +$11.2K | 0.14% | 144 |
|
2016
Q4 | $344K | Buy |
7,144
+209
| +3% | +$10.1K | 0.13% | 154 |
|
2016
Q3 | $374K | Buy |
6,935
+162
| +2% | +$8.74K | 0.15% | 131 |
|
2016
Q2 | $367K | Buy |
+6,773
| New | +$367K | 0.15% | 132 |
|